首页> 外国专利> N - (2 - hydroxyethyl) - N - methyl - 4 - (quinolin-1 (IL - 8 - 1 - (tiazn - (2 - hydroxyethyl) - N - methyl - 4 - (quinolin-1 (IL - 8 - 1 - (4 - Methyl thiazole - ylidene) piperidin-4-yl) methyl) benzamide EOL - 4 - ylmethyl) piperidin-4-yl ylidene) methyl) benzamide process for its Synthesis and its use in the process for their Synthesis and their use for e L Treatment of Pain, Anxiety and Depression Treatment of Pain, Anxiety and Depression

N - (2 - hydroxyethyl) - N - methyl - 4 - (quinolin-1 (IL - 8 - 1 - (tiazn - (2 - hydroxyethyl) - N - methyl - 4 - (quinolin-1 (IL - 8 - 1 - (4 - Methyl thiazole - ylidene) piperidin-4-yl) methyl) benzamide EOL - 4 - ylmethyl) piperidin-4-yl ylidene) methyl) benzamide process for its Synthesis and its use in the process for their Synthesis and their use for e L Treatment of Pain, Anxiety and Depression Treatment of Pain, Anxiety and Depression

机译:N-(2-羟乙基)-N-甲基-4-(喹啉-1(IL-8-1-(噻嗪-(2-羟乙基))-N-甲基-4-(喹啉-1(IL-8-1) -(4-甲基噻唑-亚烷基)哌啶-4-基)甲基)苯甲酰胺EOL-(4-甲基甲基)哌啶-4-基亚苄基)甲基)苯甲酰胺的合成方法及其在合成方法中的用途和用途治疗疼痛,焦虑和抑郁的药物治疗疼痛,焦虑和抑郁的药物

摘要

1.- N- (2-hydroxyethyl) -N-methyl-4- (quinolin-8-yl (1- (1.- N- (2-hydroxyethyl) -N-methyl-4- (quinolin-8-yl (1- (thiazol-4-ylmethyl) piperidin-4-ylidene) methyl) benzamithiazol-4-ylmethyl) piperidin-4-ylidene) methyl) benzamide, its pharmaceutically acceptable salts or its mda, its pharmaceutically acceptable salts or mixtures thereof. 2.- N- (2-hydroxyethyl) -N-methyl-4- (quinolin-ezclas. 2.- N- (2-hydroxyethyl) -N-methyl-4- (quinolin-8-yl (1- (thiazole -4-ylmethyl) piperidin-4-ylidene) methy8-yl (1- (thiazol-4-ylmethyl) piperidin-4-ylidene) methyl) benzamide 3.- A pharmaceutical composition that l) benzamide. 3. A pharmaceutical composition comprising a compound according to the claim comprises a compoundO under claim 1 or 2, a pharmacist may accept 1 or 2, and a pharmacist may accept a holder. 4. Preparation of N - (2-hydroxy) process. 4. - N - (2-hydroxy) n-methyl-4 - (piperidin-4-iden-quinlin-8-ilmeti) - n-methyl-4 - (piperidin-4-iden-quinlin-8-ilmetl) benzene zamida preparation process, including: reaction 4 - (bromine) benzene zamida, including: reactionr a 4- (bromo- {4 - [(2-hydroxyethyl) methylcarbamoyl] phenyl} methylene- {4 - [(2-hydroxyethyl) methylcarbamoyl] phenyl} methylene) piperidine protected with 8-quinolinboronic acid) acid-protected piperidine 8 -quinolinboronic to form an N- (2-hydroxyethyl) -N-methyl-4- (pipe to form an N- (2-hydroxyethyl) -N-methyl-4- (piperidin-4-ylidenoquinolin-8-ylmethyl) benzamide Protegridin-4-ylidenoquinolin-8-ylmethyl) protected benzamidey desproteger dicha N- (2-hidroxietil) -N-metilida y desproteger dicha N- (2-hidroxietil) -N-metil-4- (piperidin-4-ilidenoquinolin-8-ilmetil) benzamid-4- (piperidin-4 (o) Protected pyridine, including: 2 - (methylamine) ethanol and 4 - [bromine - (4-amino) ethanol and 4 - [bromine - (4-amino) ethanol and 4 - [bromine - (4-amino) toluene] protected pyridine. 6. A protected nil (methyl) pyridine process. 6. - N - (2-hydroxy) - n-methyl-4 - (n - (2-hydroxy) - n-methyl-4 - (piperidin-4-ilideoquinlin-8-ilmeth) triphenylbenzodiazepine1. The protected amphetamine type stimulants include: 4 - (bromine - {4 - {2gida, including: 4 - (bromine - {4 - {2 - {hydroxy}) methylamino) phenyl (RN ethylene); (methylhydroxy) phenyl (rnetline)), phenyl (rnetline) pyridine protected by 8-quinnediol acid. 7. - use 8-quinic acid to protect Idina. 7. Procedures meeting qualification requirements 66. The process in the sixth requirement also includes the reaction of 4 - (bromine - {4 - [(2-Hi) and 4 - (bromine - {4 - [(2-hydroxy) methylamino) phenyl (methylene) pyridine hydroxy) methylaminomethanol] phenyl toluene, which is protected by 8-quinic acid and keeps consistent with the acid.O 8-quinnediol can form n - (2-hydroxy) n-methyl-4 - (piperidin-4-ilar una n - (2-hydroxy) - n-methyl-4 - (piperidin-4-ideoquinlin-8-ilmetl) benzene zamida which is protected. 8. - eidenokolin-8-ilmetr) benzamida is protected. 8. Procedures to meet requirements71. Procedures under claim 7, including, but not including, the protection of N - (2-hydroxy) (2-hydroxy) and the protection of N - (2-hydroxy) (n - (piperidin-4-ilidinoquinlin-8-ilmetl) - n-methyl-4 - (piperidin-4-ilidinoquinlin-8-ilmetl) - protected benzene zamida to form n - (2-hydroxy) B1. The protected n-amides can form n - (2-hydroxy) n-methyl-4 - (piperidin-4-ideoquinlin-8-ilmetl) - n-methyl-4 - (piperidin-4-ideoquinlin-8-ilmetl) benzene zamida. 9. Procedures related to reivl. 9. Satisfactory procedures8which further comprises reacting Nindication 8, which further comprises reacting N- (2-hydroxyethyl) -N-methyl-4- (piperidin-4-ylidenoqui- (2-hydroxyethyl) -N-methyl-4- (piperidin-4 -ylidenoquinolin-8-ylmethyl) benzamide with thiazol-4-carbaldehnolin-8-ylmethyl) benzamide with thiazol-4-carbaldehyde to form N- (2-hydroxyethyl) -N-methyl-4- (quinoid to form N- (2 -hydroxyethyl) -N-methyl-4- (quinolin-8-yl (1- (thiazol-4-ylmethyl) piperidin -4-ylideneolin-8-yl (1- (thiazol-4-ylmethyl) piperidin -4-ylidene ) methyl) benzamide.) methyl) benzamide.
机译:1.- N-(2-羟乙基)-N-甲基-4-(喹啉-8-基(1-(1.- N-(2-羟乙基)-N-甲基-4-(喹啉-8-基(1-(噻唑-4-基甲基)哌啶-4-亚基)甲基)苯甲硫唑-4-基甲基)哌啶-4-亚基)甲基)苯甲酰胺,其药学上可接受的盐或其mda,其药学上可接受的盐或混合物。 2.- N-(2-羟乙基)-N-甲基-4-(喹啉-依茨克2 ..- N-(2-羟乙基)-N-甲基-4-(喹啉-8-基(1-(噻唑-4-基甲基)哌啶-4-亚甲基)甲基8-基(1-(噻唑-4-基甲基)哌啶-4-亚甲基)甲基)苯甲酰胺3.-药物组合物,其中l)为苯甲酰胺。 3.包含根据权利要求1的化合物的药物组合物,其包含根据权利要求1或2的化合物0,药剂师可以接受1或2,并且药剂师可以接受持有人。 4.制备N-(2-羟基)方法。 4.-N-(2-羟基)正甲基-4-(哌啶-4-基喹啉-8-ilmeti)-正甲基-4--(哌啶-4-基喹啉-8-ilmetl)苯zamida的制备方法,包括:反应4-(溴)苯zamida,包括:反应器a 4-(溴-{4-[((2-羟乙基)甲基氨基甲酰基]苯基}亚甲基-{4-[((2-羟乙基)甲基氨基甲酰基]苯基}亚甲基)哌啶经8-喹啉硼酸保护)酸保护的哌啶8-喹啉硼酸形成N-(2-羟乙基)-N-甲基-4-(管形成N-(2-羟乙基)-N -甲基-4-(哌啶丁-4-亚苄基喹啉-8-甲基)苯甲酰胺Protegridin-4-亚苄基喹啉-8-甲基)保护的苯甲酰胺去污剂N-(2-hidroxietil)-N-枯草杆菌和去污剂dicha N-(2- hidroxietil)-N-metil-4-(piperidin-4-ilidenoquinolin-8-ilmetil)benzamid-4-(piperidin-4(o)受保护的吡啶,包括:2-(甲胺)乙醇和4-[溴-(4 -氨基)乙醇和4- [溴-(4-氨基)乙醇和4- [溴-(4-氨基)甲苯]保护吡啶。 6.保护的无(甲基)吡啶方法。 6.-N-(2-羟基)-n-甲基-4-(n-(2-羟基)-n-甲基-4-(哌啶-4-异环喹啉-8-二甲基)三苯基苯并二氮杂1.保护的苯丙胺型兴奋剂。包括:4-(溴-{4-{2gida,包括:4-(溴-{4-{2- {羟基})甲基氨基)苯基(RN乙烯);(甲基羟基)苯基(Rnetline)),苯基(Rnetline )被8-奎宁二醇酸保护的吡啶。 7.-使用8-奎宁酸保护Idina。 7.符合资格要求的程序66.第六项要求的过程还包括4-(溴-{4--((2-Hi))和4-(溴-{4--((2-羟基)甲基氨基)苯基(亚甲基)吡啶羟基)甲基氨基甲醇]苯基甲苯,由8-奎宁酸保护并与该酸保持一致。O8-奎宁二醇可形成n-(2-羟基)n-甲基-4-(哌啶4 -被保护的n-(2-羟基)-n-甲基-4-(哌啶丁-4-ideoquinlin-8-ilmetl)苯叠氮。8.-eidenokolin-8-ilmetr)被保护的苯甲酰胺。 8.符合要求的程序71。 8.根据权利要求7的方法,包括但不包括对N-(2-羟基)(2-羟基)的保护和对N-(2-羟基)(n-(哌啶子基-4-ilidinoquinlin-8-ilmetl)的保护)-n-甲基-4--(哌啶-4-异丁喹啉-8-ilmetl)-保护的苯叠氮化合物形成n-(2-羟基)B1。保护的n-酰胺可形成n-(2-羟基)n-甲基-4-(哌啶丁-4-ideoquinlin-8-ilmetl)-n-甲基-4--(哌啶丁-4-ideoquinlin-8-ilmetl)苯扎米达9.与reivl相关的程序9.令人满意的程序8,该程序还包括进行反应标记8,其进一步包括使N-(2-羟乙基)-N-甲基-4-(哌啶-4-基吡啶基-(2-羟乙基)-N-甲基-4-(哌啶-4-羟基喹啉-8-基甲基)反应。 )苯甲酰胺与噻唑-4-碳杂苯并啉-8-基甲基)苯甲酰胺与噻唑-4-碳醛形成N-(2-羟乙基)-N-甲基-4-(醌型形成N-(2-羟乙基)-N-甲基-4-(喹啉-8-基(1-(噻唑-4-基甲基))哌啶丁-4-亚萘基-8-基(1-(噻唑-4-基甲基)哌啶-4-亚烷基)甲基)苯甲酰胺。)甲基)苯甲酰胺。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号